INLF

Quanzhou, China, Oct. 20, 2026 (GLOBE NEWSWIRE) -- INLIF LIMITED (Nasdaq: INLF) (together with all its subsidiaries and consolidated entities, the “Company” or “INLIF”), a company engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms, today announced the closing of its previously announced registered direct offering conducted on a best-efforts basis.

Quanzhou, China, Oct. 19, 2026 (GLOBE NEWSWIRE) -- INLIF LIMITED (Nasdaq: INLF) (together with all its subsidiaries and consolidated entities, the "Company" or "INLIF"), a company engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms, today announced that it has entered into securities purchase agreements with certain institutional investors for the purchase and sale of an aggregate of 435,000 Class A Ordinary Shares, par value of US$0.0001 per share, of the Company (the “Ordinary Shares”), pre-funded warrants to purchase up to 1,908,750 Ordinary Shares (the “Pre-Funded Warrants”), Series A warrants to initially purchase up to 2,343,750 Ordinary Shares (the “Series A Warrants”), Series B warrants to initially purchase up to 2,343,750 units (the “Series B Warrants”, each unit consisting of one Ordinary Share, or one Pre-Funded Warrant in lieu thereof and one Series A Warrant ), and Series C warrants to purchase a number of Ordinary Shares to be determined in accordance with their terms (the “Series C Warrants” and, together with the Series A Warrants and the Series B Warrants, the “Ordinary Warrants”), in a registered direct offering (the “Offering”). Each Ordinary Share or Pre-Funded Warrant will be sold together with one accompanying Series A Warrant, one accompanying Series B Warrant and one accompanying Series C Warrant at a combined purchase price of US$1.60 per Ordinary Share and accompanying Ordinary Warrants, or US$1.5999 per Pre-Funded Warrant and accompanying Ordinary Warrants, which equals the combined purchase price per Ordinary Share and accompanying Ordinary Warrants minus US$0.0001, the exercise price of each Pre-Funded Warrant. The aggregate gross proceeds from the Offering are expected to be approximately US$3.75 million, prior to deducting placement agent fees, legal fees, administrative and other offering-related expenses.

QUANZHOU, China, Sept. 24, 2026 /PRNewswire/ -- INLIF LIMITED (Nasdaq: INLF) (together with all its subsidiaries and consolidated entities, the "Company" or "INLIF"), a company engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms, today announced its unaudited fi nancial results for the first half of fiscal year 2026 ended June 30, 2026.

QUANZHOU, China, Sept. 16, 2026 (GLOBE NEWSWIRE) -- INLIF LIMITED (NASDAQ: INLF) (together with all its subsidiaries and consolidated entities, the “Company” or “INLIF”), a company engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms, today announced the results of the Company's Extraordinary General Meeting (the "Meeting") held at 9:30 a.m. U.S. Eastern Time on September 15, 2026. The proposals submitted for shareholder approval at the Meeting have been approved. Specifically, the shareholders have duly passed the following resolutions:

QUANZHOU, China, Sept. 09, 2026 (GLOBE NEWSWIRE) -- INLIF LIMITED (NASDAQ: INLF) (together with all its subsidiaries and consolidated entities, the “Company” or “INLIF”), a company engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms, today announced that its Extraordinary General Meeting of Shareholders (the “Meeting”), convened on September 8, 2026 at 9:30 a.m.

DENVER, Aug. 05, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- INLIF (NASDAQ:INLF) emerged as a top gainer after investors focused on the company's upcoming Extraordinary General Meeting (EGM) scheduled for August 17, 2026, where shareholders will vote on a series of significant capital structure proposals that could reshape the company's share base. The proposed resolutions include a substantial increase in authorized share capital, expanding from approximately 1.09 million authorized shares to 8.5 billion authorized shares, followed by a reduction in the par value of each ordinary share from US$0.32 to US$0.0001.

QUANZHOU, China, July 30, 2026 (GLOBE NEWSWIRE) -- INLIF LIMITED (NASDAQ: INLF) (together with all its subsidiaries and consolidated entities, the “Company” or “INLIF”), a company engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms, today announced that it will hold an extraordinary general meeting of shareholders (the “EGM”) at No. 88, Hongsi Road, Yangxi New Area, Honglai Town, Nan'an City, Quanzhou, the People's Republic of China, at 9:30 a.m. U.S. Eastern Time on August 17, 2026.

QUANZHOU, China, June 30, 2026 (GLOBE NEWSWIRE) -- INLIF LIMITED (NASDAQ: INLF) (together with all its subsidiaries and consolidated entities, the “Company” or “INLIF”), a company engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms, today announced that its Board of Directors has approved a 1-for-200 share combination of all its authorized and issued ordinary shares, including both Class A ordinary shares and Class B ordinary shares (the “Second Share Combination”), pursuant to the authorization granted from an extraordinary general meeting of the Company's shareholders on January 9, 2026 (the “EGM”).

Next-Generation Robot Demonstrates High-Dynamic Motion Capabilities in Experimental Testing QUANZHOU, China, June 18, 2026 (GLOBE NEWSWIRE) -- INLIF LIMITED (NASDAQ: INLF) (together with all its subsidiaries and consolidated entities, the “Company” or “INLIF”), a company engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms, today announced its strategic entry into the humanoid robotics market. According to industry trends and market developments observed by the Company, the industry of humanoid robotics is currently at a critical stage in the transition from technology validation to industrialization.

QUANZHOU, China, June 10, 2026 (GLOBE NEWSWIRE) -- INLIF LIMITED (NASDAQ: INLF) (together with all its subsidiaries and consolidated entities, the “Company” or “INLIF”), a company engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms, today announced that it has completed the commercial delivery confirmation for its first order of battery cell packing machines, with a total contract value of nearly RMB 30 million (approximately US$4.4 million). This achievement demonstrates the Company's continuous expansion into the new energy intelligent equipment sector, following its strategic focus on the industry since 2025.